RTIs account for around 60% of global antibiotic prescribing and are a key driver of AMR
Related Posts
Kanabo and City Dock Pharmacy team up
Companies collaborate to launch walk-in pain clinic Kanabo Group has linked up with City Dock Pharmacy in London, to introduce a walk-in pain clinic offering […]
Shane Olwill – PharmaTimes
Asgard Therapeutics has appointed Shane Olwill as Chief Development Officer Asgard Therapeutics, a privately held biotech company pioneering in vivo direct cell reprogramming for cancer immunotherapy, has […]
Heart vests to identify those at high risk of sudden cardiac death
In the UK, heart rhythms affect around two million people and can cause sudden death A re-useable heart vest developed by researchers […]